Localized Prostate Cancer in Patients Under the Age of 60

Akim Kogui Douro

doi:10.26717/bjstr.2021.33.005376

Abstract

Prostate cancer (PCa) remains the second cause of cancer death in men, it is a public health problem especially in elderly patients with 35.5% cases diagnosed after 75 years...

Highlights

Prostate cancer (PCa) remains the second cause of cancer death in men, it is a public health problem especially in elderly patients with 35.5% cases diagnosed after 75 years. it is rare before the age of 60 with 9%
Through the study 20 cases of localized PCa in patients under 60 years treated by Radical prostatectomy (RP) carried out in the urology department of the military teaching hospital of Rabat and a review of the different published series, we propose to analyze the particularities of this cancer in this age group
This is a retrospective study including all patients treated for localized PCa by RP and whose age is less than 60 years at the Mohamed V Military teaching Hospital in Rabat between January 2004 and October 2014.To analyze the particularities of localized PCa in patients aged less than 60 years, we were interested in the following parameters: age, diagnostic circumstances, prostate specific antigen (PSA) level, extension assessment, TNM stage, preoperative and postoperative clinical and pathological evaluation

Summary

Introduction

Prostate cancer (PCa) remains the second cause of cancer death in men, it is a public health problem especially in elderly patients with 35.5% cases diagnosed after 75 years. it is rare before the age of 60 with 9%. Prostate cancer (PCa) remains the second cause of cancer death in men, it is a public health problem especially in elderly patients with 35.5% cases diagnosed after 75 years. The risk factors for PCa are the age melanoderm ethnicity and a family history of PCa, in which case they occur five to ten years earlier than in the general population [1,2]. The Screening of Pca is based on digital rectal examination (DRE) and rate of the prostate specific antigen (PSA) [5,6,7]. Since the use of PSA as a test for Pca, more and more young men are diagnosed in the early stages of the disease [5,6]. Few published data regarding PCa in young men have reported conflicting results. Some have suggested that PCa in young men has a better prognosis than that in older men, while others have reported an unfavorable prognosis [7,8]

Methods

Results

Discussion

Conclusion